Clinical Trial

Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Molecular classification that has been recently incorporated in FIGO classification of endometrial cancer is a new triage tool for the better management of endometrial cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-03.
Trial Details
NCT Number NCT06584630
Lead Sponsor Aristotle University Of Thessaloniki
Conditions Endometrial Cancer
Enrollment 80 participants
Start Date 2022-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-19